Company intelligence / Profile preview

China General Nuclear Power Group

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

CGN focuses primarily on nuclear and renewable energy but has ventured into healthcare through proton therapy technology. It is primarily an energy company, but has produced the first domestically manufactured proton therapy cyclotron, which is part of its commitment to advancing cancer treatment technologies. The company is not directly involved in biotechnology or pharmaceuticals but plays a role in healthcare through its non-nuclear applications.

Therapeutic areas: Oncology
Industry: Therapeutic Medical Devices

Partnerships

Ion Beam Applications (IBA) for proton therapy technology

Beyond the preview

Go deeper on China General Nuclear Power Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China General Nuclear Power Group.

Explore the full profile